Identification of Novel Cdc7 Kinase Inhibitors as Anti-Cancer Agents That Target the Interaction With Dbf4 by the Fragment Complementation and Drug Repositioning Approach

EBioMedicine - Netherlands

doi 10.1016/j.ebiom.2018.09.030